Journal of Cardiac Failure
Volume 14, Issue 5 , Pages 407-413 , June 2008

Effects of Yoga on Inflammation and Exercise Capacity in Patients With Chronic Heart Failure

  • Paula R. Pullen, MEd

      Affiliations

    • Department of Kinesiology and Health, Georgia State University, Atlanta, Georgia
    • ,
  • Sameer H. Nagamia, MD

      Affiliations

    • Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Puja K. Mehta, MD

      Affiliations

    • Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Walter R. Thompson, PhD

      Affiliations

    • Department of Kinesiology and Health, Georgia State University, Atlanta, Georgia
    • ,
  • Dan Benardot, PhD

      Affiliations

    • Division of Nutrition, School of Health Professions Georgia State University, Atlanta, Georgia
    • ,
  • Ramadan Hammoud, MD

      Affiliations

    • Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Janice M. Parrott, RN

      Affiliations

    • Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Srikanth Sola, MD

      Affiliations

    • Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Bobby V. Khan, MD, PhD

      Affiliations

    • Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia
    • Corresponding Author InformationReprint requests: Bobby V. Khan, MD, PhD, Emory University School of Medicine, Division of Cardiology, Grady Memorial Hospital, Vascular Research Laboratory, 69 Jesse Hill Drive SE, #C247, Atlanta, GA 30303.

Received 29 June 2007 ,Revised 17 December 2007 ,Accepted 20 December 2007.

References 

  1. Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA. 2002;287:628–640
  2. Adams KF, Zannad F. Clinical definition and epidemiology of advanced heart failure. Am Heart J. 1998;135:S204–S215
  3. Bennett SJ, Pressler ML, Hays L, Firestine LA, Huster GA. Psychosocial variables and hospitalization in persons with chronic heart failure. Prog Cardiovasc Nurs. 1997;12:4–11
  4. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc. 1990;38:1290–1295
  5. Walke LM, Gallo WT, Tinetti ME, Fried TR. The burden of symptoms among community-dwelling older persons with advanced chronic disease. Arch Intern Med. 2004;164:2321–2324
  6. Wenger NK. Quality of life: can it and should it be assessed in patients with heart failure?. Cardiology. 1989;76:391–398
  7. Pepi M, Agostoni P, Marenzi G, Dorai E, Guazzi M, Lauri G, et al. The influence of diastolic and systolic function on exercise performance in heart failure due to dilated cardiomyopathy or ischemic heart disease. Eur J Heart Fail. 1999;1:161–167
  8. Smart N, Haluska B, Leano R, Case C, Mottram PM, Marwick TH. Determinants of functional capacity in patients with chronic heart failure: role of filling pressure and systolic and diastolic function. Am Heart J. 2005;149:152–158
  9. Walke LM, Byers AL, Gallo WT, Endrass J, Fried TR. The association of symptoms with health outcomes in chronically ill adults. J Pain Symptom Manage. 2007;33:58–66
  10. Kleiner C. Mind-body fitness. Yoga booms in popularity as a way to heighten flexibility, improve breathing, and gain sanity. US News World Rep. 2002;132:53–55
  11. Bulavin VV, Kliuzhev VM, Kliachkin LM, Lakshmankumar , Zuikhin ND, Vlasova TN. [Elements of yoga therapy in the combined rehabilitation of myocardial infarct patients in the functional recovery period]. Vopr Kurortol Fizioter Lech Fiz Kult. 1993;7–9
  12. Telles S, Naveen KV. Yoga for rehabilitation: an overview. Indian J Med Sci. 1997;51:123–127
  13. Bernardi L, Gabutti A, Porta C, Spicuzza L. Slow breathing reduces chemoreflex response to hypoxia and hypercapnia, and increases baroreflex sensitivity. J Hypertens. 2001;19:2221–2229
  14. Bernardi L, Sleight P, Bandinelli G, Cencetti S, Fattorini L, Wdowczyc-Szulc J, et al. Effect of rosary prayer and yoga mantras on autonomic cardiovascular rhythms: comparative study. BMJ. 2001;323:1446–1449
  15. Selvamurthy W, Sridharan K, Ray US, Tiwary RS, Hegde KS, Radhakrishan U, et al. A new physiological approach to control essential hypertension. Indian J Physiol Pharmacol. 1998;42:205–213
  16. Mahajan AS, Reddy KS, Sachdeva U. Lipid profile of coronary risk subjects following yogic lifestyle intervention. Indian Heart J. 1999;51:37–40
  17. Lakshmikanthan C, Alagesan R, Thanikachalam S, Ramamurthi B, Elangovan D, Viswanathan TR, et al. Long term effects of yoga on hypertension and/or coronary artery disease. J Assoc Physicians India. 1979;27:1055–1058
  18. Tulpule TH, Shah HM, Shah SJ, Haveliwala HK. Yogic exercises in the management of ischaemic heart disease. Indian Heart J. 1971;23:259–264
  19. Ornish D. Can lifestyle changes reverse coronary heart disease?. World Rev Nutr Diet. 1993;72:38–48
  20. Ornish D, Scherwitz LW, Doody RS, Kesten D, McLanahan SM, Brown SE, et al. Effects of stress management training and dietary changes in treating ischemic heart disease. JAMA. 1983;249:54–59
  21. Petersen JW, Felker GM. Inflammatory biomarkers in heart failure. Congest Heart Fail. 2006;12:324–328
  22. Chin BS, Conway DS, Chung NA, Blann AD, Gibbs CR, Lip GY. Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis. Blood Coagul Fibrinolysis. 2003;14:515–521
  23. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506–512
  24. Landmesser U, Merten R, Spiekermann S, Buttner K, Drexler H, Hornig B. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation. 2000;101:2264–2270
  25. American College of Sports Medicine's guidelines for exercise testing and prescription. 7th ed.. Baltimore, MD: Lippincott Williams & Wilkins; 2005;
  26. Lohman TG, Roche AF, Martoll R. Anthropometric standardization reference manual, abridged edition. Champaign, IL: Human Kinetic Books; 1991;
  27. Khan BV, Sola S, Lauten WB, Natarajan R, Hooper WC, Menon RG, et al. Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome. Diabetes Care. 2004;27:1712–1715
  28. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J. 1992;124:1017–1025
  29. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol. 1993;71:1106–1107
  30. Bennett SJ, Oldridge NB, Eckert GJ, Embree JL, Browning S, Hou N, et al. Comparison of quality of life measures in heart failure. Nurs Res. 2003;52:207–216
  31. Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997;157:99–104
  32. Zannad F, Briancon S, Juilliere Y, Mertes PM, Villemot JP, Alla F, et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol. 1999;33:734–742
  33. Perlman LV, Ferguson S, Bergum K, Isenberg EL, Hammarsten JF. Precipitation of congestive heart failure: social and emotional factors. Ann Intern Med. 1971;75:1–7
  34. Johnson W, Omland T, Hall C, Lucas C, Myking OL, Collins C, et al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol. 2002;39:1623–1629
  35. Sigurdsson A, Swedberg K. The role of neurohormonal activation in chronic heart failure and postmyocardial infarction. Am Heart J. 1996;132:229–234
  36. Abdulla J, Kober L, Christensen E, Torp-Pedersen C. Effect of beta-blocker therapy on functional status in patients with heart failure–a meta-analysis. Eur J Heart Fail. 2006;8:522–531
  37. Abdulla J, Pogue J, Abildstrom SZ, Kober L, Christensen E, Pfeffer MA, et al. Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction—a meta-analysis. Eur J Heart Fail. 2006;8:90–96
  38. La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351:478–484
  39. La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R, et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation. 2001;103:2072–2077
  40. Mortara A, La Rovere MT, Pinna GD, Parziale P, Maestri R, Capomolla S, et al. Depressed arterial baroreflex sensitivity and not reduced heart rate variability identifies patients with chronic heart failure and nonsustained ventricular tachycardia: the effect of high ventricular filling pressure. Am Heart J. 1997;134:879–888
  41. Hachamovitch R, Brown HV, Rubin SA. Respiratory and circulatory analysis of CO2 output during exercise in chronic heart failure. Circulation. 1991;84:605–612
  42. Tran MD, Holly RG, Lashbrook J, Amsterdam EA. Effects of hatha yoga practice on the health-related aspects of physical fitness. Prev Cardiol. 2001;4:165–170
  43. Damodaran A, Malathi A, Patil N, Shah N, Suryavansihi , Marathe S. Therapeutic potential of yoga practices in modifying cardiovascular risk profile in middle aged men and women. J Assoc Physicians India. 2002;50:633–640
  44. Murugesan R, Govindarajulu N, Bera TK. Effect of selected yogic practices on the management of hypertension. Indian J Physiol Pharmacol. 2000;44:207–210
  45. Havranek EP, Ware MG, Lowes BD. Prevalence of depression in congestive heart failure. Am J Cardiol. 1999;84:348–350A9
  46. Friedmann E, Thomas SA, Liu F, Morton PG, Chapa D, Gottlieb SS. Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J. 2006;152:940.e1–940.e8
  47. Cohen S, Herbert TB. Health psychology: psychological factors and physical disease from the perspective of human psychoneuroimmunology. Annu Rev Psychol. 1996;47:113–142
  48. Kiecolt-Glaser JK, Glaser R. Psychoneuroimmunology: can psychological interventions modulate immunity?. J Consult Clin Psychol. 1992;60:569–575
  49. Visintainer MA, Volpicelli JR, Seligman ME. Tumor rejection in rats after inescapable or escapable shock. Science. 1982;216:437–439
  50. Adamopoulos S, Parissis J, Kroupis C, Georgiadis M, Karatzas D, Karavolias G, et al. Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J. 2001;22:791–797
  51. Taddei S, Galetta F, Virdis A, Ghiadoni L, Salvetti G, Franzoni F, et al. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation. 2000;101:2896–2901
  52. Sivasankaran S, Pollard-Quintner S, Sachdeva R, Pugeda J, Hoq SM, Zarich SW. The effect of a six-week program of yoga and meditation on brachial artery reactivity: do psychosocial interventions affect vascular tone?. Clin Cardiol. 2006;29:393–398
  53. Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology. 2002;13:561–568

PII: S1071-9164(07)01166-9

doi: 10.1016/j.cardfail.2007.12.007

Journal of Cardiac Failure
Volume 14, Issue 5 , Pages 407-413 , June 2008

Article Tools

* Image Usage & Resolution